Post by Lloyd Price
Partner at Nelson Advisors > Healthcare Technology Investment Banking specialising in European HealthTech, MedTech, Healthcare AI, Health IT
The Healthcare AI Gold Rush Is Over: New Playbook Outlines Framework for Longevity https://lnkd.in/e2qXTn_R The speculative "gold rush" in healthcare artificial intelligence, characterised by a feverish pace of unbridled investment and a technology-first approach to product development, has concluded. A new, more discerning market has emerged, defined not by the promise of an algorithm but by a strategic fusion of technological efficacy, market access, and quantifiable value. This report provides a detailed analysis of this new equilibrium. The distinction between "thrivers" and "survivors" in this evolving landscape is predicated on three fundamental strategic pillars: the ability to deeply own a critical workflow, the foresight to secure distribution channels before launching a product, and the discipline to prove a measurable return on investment (ROI). As the market accelerates toward a projected value of over $500 billion by 2032, the primary beneficiaries will be those who have mastered this new playbook. The high-profile failures of ventures like IBM Watson Health and Babylon Health serve as cautionary tales, demonstrating that even immense capital and advanced technology are insufficient without a foundational understanding of the healthcare system's complex, human-centric realities. The future of healthcare AI is not just about intelligent technology; it is about intelligence meticulously embedded in the service of trusted, efficient, and equitable care. https://lnkd.in/e2qXTn_R